Discontinuation report DIFLUNISAL
Report ID | 108367 |
Drug Identification Number | 02039494 |
Brand name | DIFLUNISAL |
Common or Proper name | DIFLUNISAL |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | DIFLUNISAL |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BTL |
ATC code | N02BA |
ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-03-10 |
Remaining supply date | 2020-03-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.